LEIDOS Aktie

 

Leidos (LDOS) concluded the recent trading session at $160.21, signifying a -2.11% move from its prior day's close....

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards....

Co-written by Leidos Chief Behavioral Health Officer Dr. Keita Franklin and guest author PsychArmor Chief Executive Officer Dr. Tina Atherall NORTHAMPTON, MA / ACCESS Newswire / July 14, 2025 / Soc......

Marines Test 'Narco Sub' With An Eye On War With China Taking creative inspiration from Latin American drug traffickers, the United States Marines Corps is testing low-profile "narco subs" intended for potential use in the Indo-Pacific theater. The Marines have another term and -- of course -- an acronym for the concept: the Autonomous Low-Profile Vessel (ALVP) program. The low-profile, unmanned Sea Specter would be most valuable in scenarios where the US foe is a "near-peer" like China (Leidos photo) The unmanned vessel being tested by II Marine Expeditionary Force is called the "Sea Specter," and it's produced by Gibbs & Cox, is a subsidiary of Reston, VA-based Leidos.  “I think that it's OK to say that those narco subs inspired the concept, but that's where the similarities end,” Gibbs & Cox chief engineering officer Jeff Bowles told Defense One. “Narco subs are dirty. They're dangerous. They're not engineered. But in principle, their mission i...

According to the average brokerage recommendation (ABR), one should invest in Leidos (LDOS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?...

Leidos Holdings will release its second-quarter earnings next month, and analysts anticipate bottom-line to be in-line with the year-ago quarter....

Leidos (LDOS) reached $162.09 at the closing of the latest trading day, reflecting a -1.44% change compared to its last close....

RESTON, Va., July 8, 2025 /PRNewswire/ -- Leidos (NYSE: LDOS) today announced it has scheduled a conference call for Tuesday, August 5, 2025, at 8 a.m. (ET) to announce its second quarter 2025 financial results for the period ending July 4, 2025, with the company planning to issue its......

Leidos (LDOS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report....

In the closing of the recent trading day, Leidos (LDOS) stood at $157.76, denoting a +1.34% move from the preceding trading day....

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores....

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage....

Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards....

As defense and aerospace tech converge, LDOS and RTX tap rising budgets, AI tools and next-gen missile defense to fuel growth....

Latest Ratings for LDOS DateFirmActionFromTo Mar 2022Goldman SachsMaintainsBuy Jan 2022BarclaysMaintainsOverweight Nov 2021Wells FargoMaintainsOverweight View More Analyst Ratings for LDOS View the Latest Analyst Ratings read more...

LDOS' rising backlog signals steady revenue gains and stronger future cash flows....

As Leidos Holdings has outpaced the Dow recently, analysts remain moderately optimistic about the stock's prospects....

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

RESTON, Va., June 17, 2025 /PRNewswire/ -- By modernizing the Defense Information Systems Agency (DISA) tools that transfer critical data between classified and unclassified networks, Leidos (NYSE: LDOS) will help accelerate decision making across the Department of Defense (DoD). Under a......

Based on the average brokerage recommendation (ABR), Leidos (LDOS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?...